Clinical trials
Phase 2 Adenocarcinoma of Lung trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First People's Hospital of Hangzhou | 2 |
| Fujian Cancer Hospital | 2 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 2 |
| Henan Cancer Hospital | 2 |
| National Cancer Center, Korea | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Hope Cancer Institute, Inc. | 1 |
| Hunan Cancer Hospital | 1 |
| Samsung Medical Center | 1 |
| Shanghai Chest Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 19 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Lung Neoplasms | 7 |
| Adenocarcinoma, Bronchiolo-Alveolar | 3 |
| Adenocarcinoma | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.